Latest filing published 24 Jun 2020 for TG Therapeutics, INC., €126k.
Filing timeline
BuySaleInsider track record
William James Kennedy: trading record in brief
William James Kennedy discloses dealings in TG Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 16 May 2012 to 22 June 2020, the count stands at 14 filings.
Sales make up the whole of the open-market record (4 sales, €762k). Other entries cover 10 share grants. In 2020 alone, the filings show no purchases and 1 sale.
Most recently, on 24 June 2020, the filings show an open-market sale worth €126k in TG Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William James Kennedy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,745 shares@ US$18.27100.0% of flowCOMMON STOCKSEC:0001104659-20-076542:0
- 15,000 shares0COMMON STOCKSEC:0001104659-20-076542:1
- 27,048 shares0COMMON STOCKSEC:0001654954-19-010886:0
- 15,000 shares0COMMON STOCKSEC:0001654954-18-007120:0
- 25,071 shares@ US$13.4558.3% of flowCOMMON STOCKSEC:0001654954-18-006742:0
- 15,000 shares0COMMON STOCKSEC:0001654954-17-005708:0
- 8,548 shares@ US$10.2716.5% of flowCOMMON STOCKSEC:0001654954-17-003280:0
- 12,459 shares0COMMON STOCKSEC:0001144204-16-112312:0
- 17,000 shares@ US$17.08COMMON STOCKSEC:0001144204-15-041875:0
- 4,667 shares0COMMON STOCKSEC:0001144204-15-035882:0
- 11,538 shares0COMMON STOCKSEC:0001144204-14-036684:0
- 8,404 shares0COMMON STOCKSEC:0001144204-13-033955:0
- 8,881 shares0COMMON STOCKSEC:0001144204-13-016159:0
- 50,000 shares0COMMON STOCKSEC:0001144204-12-030406:0
14 of 14 declarations